Icon is committed to delivering clinical trials and research programs to our patients, offering Australia’s largest private cancer clinical trials program. Icon currently has 37 clinical trials open for recruitment, and has 50 active studies closed for recruitment with patients in treatment and follow-up, and over 300 patients currently on active trials across haematology, medical oncology and radiation oncology. This includes clinical trials sponsored by the pharmaceutical industry, along with collaborative studies undertaken in partnership with various universities and collaborative groups.
It is important to us that you and your loved ones are kept well informed and supported throughout the trial process. We employ a team of nurses, clinical trial coordinators and data managers to coordinate and manage the needs of each patient across the entire period of the trial.
By providing access to a wide-range of clinical trials across a multitude of cancer types, Icon helps to contribute to breakthroughs and advancements in cancer treatments for the benefit of current and future patients.